Format

Send to

Choose Destination
Clin Infect Dis. 2003 Jul 15;37(2):311-3. Epub 2003 Jul 9.

Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.

Author information

1
Department of Internal Medicine, Hospital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Abstract

Fusarium infection is known to cause major morbidity and mortality in immunocompromised hosts. We report the successful treatment of disseminated Fusarium infection with skin manifestations in a severely neutropenic, immunocompromised host with voriconazole, a new second-generation triazole. Voriconazole might be an alternative therapy for patients with neutropenia who have fusariosis that is refractory or unresponsive to amphotericin B or its liposomal formulation.

PMID:
12856225
DOI:
10.1086/375842
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center